KRAS and ovarian carcinoma: Recent genome-wide analysis by TCGA, single nucleotide polymorphism arrays identified KRAS and MAPK1 as two of the most frequently amplified genes in high-grade serous ovarian carcinomas with the prototypic type in type II ovarian carcinomas [6].